Matthew Scott Harris, Chief Medical Officer at Altimmune, Inc. (ALT), bought 10,000 shares at $4.22 ($42K) on 2023-03-23, disclosed to the SEC on 2023-03-23.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |